Main text

Mai NTH, Dobbs N, Phu NH, Colas RA, Thao LTP, Thuong NTT, Nghia HDT, Hanh NHH, Hang NT, Heemskerk AD, Day JN, Ly L, Thu DDA, Merson L, Kestelyn E, Wolbers M, Geskus R, Summers D, Chau NVV, Dalli J, Thwaites GE. 2018. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. eLife 7:e33478. doi: 10.7554/eLife.33478.

Published 27 February 2018

We have recently been notified via PubPeer that the illustration we employed in our publications to denote presence of lipid mediators in the samples of interest has been interpreted as raw data. As this panel was strictly meant to be an illustration, we provide a revised figure presenting chromatograms supporting the presence of each of the reported mediators.

The corrected Figure 3—figure supplement 1 is shown here:

The original Figure 3—figure supplement 1 is shown here for reference:

We have also clarified the Data availability statement. The revised statement reads:

The Oxford University Clinical Research Unit (OUCRU) operates managed open access to the research data it generates, which complies with the policies of its major funder, the Wellcome Trust, UK. The objective is not to restrict access to data, but to monitor who uses the data and for what purpose, and to ensure those responsible for collecting and curating the data are appropriately acknowledged by those using it. Therefore, those wishing to acquire the anonymized dataset, including LC-MS/MS data, from which the results presented in this manuscript were produced should email the trial Chief Investigator and corresponding author, Professor Guy Thwaites (gthwaites@oucru.org).

The original statement read

The Oxford University Clinical Research Unit (OUCRU) operates managed open access to the research data it generates, which complies with the policies of its major funder, the Wellcome Trust, UK. The objective is not to restrict access to data, but to monitor who uses the data and for what purpose, and to ensure those responsible for collecting and curating the data are appropriately acknowledged by those using it. Therefore, those wishing to acquire the anonymized dataset from which the results presented in this manuscript were produced should email the trial Chief Investigator and corresponding author, Professor Guy Thwaites (gthwaites@oucru.org).

The article has been corrected accordingly.

Article and author information

Author details

  1. Nguyen Thi Hoang Mai

  2. Nicholas Dobbs

  3. Nguyen Hoan Phu

  4. Romain A Colas

  5. Le TP Thao

  6. Nguyen TT Thuong

  7. Ho DT Nghia

  8. Nguyen HH Hanh

  9. Nguyen T Hang

  10. A Dorothee Heemskerk

  11. Lucy Ly

  12. Do DA Thu

  13. Marcel Wolbers

  14. Ronald Geskus

  15. David Summers

  16. Nguyen VV Chau

  17. Jesmond Dalli

Publication history

  1. Version of Record published: March 21, 2023 (version 1)

Copyright

© 2023, Mai et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 114
    Page views
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nguyen Thi Hoang Mai
  2. Nicholas Dobbs
  3. Nguyen Hoan Phu
  4. Romain A Colas
  5. Le TP Thao
  6. Nguyen TT Thuong
  7. Ho DT Nghia
  8. Nguyen HH Hanh
  9. Nguyen T Hang
  10. A Dorothee Heemskerk
  11. Jeremy N Day
  12. Lucy Ly
  13. Do DA Thu
  14. Laura Merson
  15. Evelyne Kestelyn
  16. Marcel Wolbers
  17. Ronald Geskus
  18. David Summers
  19. Nguyen VV Chau
  20. Jesmond Dalli
  21. Guy E Thwaites
(2023)
Correction: A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults
eLife 12:e87888.
https://doi.org/10.7554/eLife.87888